The table below shows GoodRx Holdings, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$194.01M
$196.03M
$203.07M
$202.97M
$195.25M
$200.61M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$30.18M
$31.01M
$29.93M
$31.14M
$30.14M
$30.85M
GDRX annual revenue (10-K history)
GoodRx Holdings, Inc. reported annual revenue of $796.85M for fiscal year 2025. That is up 0.6% from $792.32M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $249.52M (FY 2018) to $796.85M. Figures come from the company's audited annual reports as filed with the SEC.
